Ubs Group Ag Keros Therapeutics, Inc. Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 174,941 shares of KROS stock, worth $2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

174,941

Previous 55,907 212.91%

Holding current value

$2 Million

Previous $3.25 Million 14.7%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$15.64 - $70.0 $1.86 Million - $8.33 Million	119,034 Added 212.91%	174,941 $2.77 Million
Q3 2024 Nov 14, 2024	SELL	$41.68 - $58.07 $402,128 - $560,259	-9,648 Reduced 14.72%	55,907 $3.25 Million
Q2 2024 Aug 13, 2024	SELL	$44.58 - $66.89 $2.61 Million - $3.92 Million	-58,630 Reduced 47.21%	65,555 $3 Million
Q1 2024 May 13, 2024	SELL	$41.26 - $70.48 $2.36 Million - $4.03 Million	-57,200 Reduced 31.54%	124,185 $8.22 Million
Q4 2023 Feb 09, 2024	BUY	$27.12 - $41.05 $4.74 Million - $7.18 Million	174,798 Added 2653.68%	181,385 $7.21 Million
Q3 2023 Nov 09, 2023	SELL	$31.57 - $43.02 $730,182 - $995,009	-23,129 Reduced 77.83%	6,587 $209,000
Q2 2023 Aug 11, 2023	SELL	$37.26 - $51.01 $124,262 - $170,118	-3,335 Reduced 10.09%	29,716 $1.19 Million
Q1 2023 May 12, 2023	SELL	$41.44 - $59.32 $668,344 - $956,712	-16,128 Reduced 32.79%	33,051 $1.41 Million
Q4 2022 Feb 08, 2023	SELL	$39.45 - $51.77 $4.5 Million - $5.9 Million	-114,060 Reduced 69.87%	49,179 $2.36 Million
Q3 2022 Nov 10, 2022	SELL	$27.8 - $40.12 $936,192 - $1.35 Million	-33,676 Reduced 17.1%	163,239 $6.14 Million
Q2 2022 Aug 10, 2022	SELL	$26.03 - $67.04 $72,051 - $185,566	-2,768 Reduced 1.39%	196,915 $5.44 Million
Q1 2022 May 16, 2022	BUY	$42.12 - $59.36 $1.86 Million - $2.62 Million	44,068 Added 28.32%	199,683 $10.9 Million
Q4 2021 Feb 14, 2022	BUY	$36.95 - $62.89 $954,529 - $1.62 Million	25,833 Added 19.9%	155,615 $9.11 Million
Q3 2021 Nov 15, 2021	BUY	$29.27 - $43.71 $3.76 Million - $5.61 Million	128,362 Added 9039.58%	129,782 $5.14 Million
Q2 2021 Aug 13, 2021	SELL	$42.4 - $70.11 $599,832 - $991,846	-14,147 Reduced 90.88%	1,420 $60,000
Q1 2021 May 12, 2021	BUY	$54.0 - $75.28 $827,172 - $1.15 Million	15,318 Added 6151.81%	15,567 $958,000
Q4 2020 Feb 11, 2021	BUY	$36.0 - $82.74 $8,964 - $20,602	249 New	249 $18,000
Q3 2020 Nov 12, 2020	SELL	$27.04 - $62.21 $59,677 - $137,297	-2,207 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$20.08 - $40.39 $44,316 - $89,140	2,207 New	2,207 $83,000

Others Institutions Holding KROS

# of Institutions

177

Shares Held

31.1M

Call Options Held

646K

Put Options Held

670K

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $295M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account